Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study.
Filipa Alves da CostaKaterina Mala-LadovaVivian LeeSalvador TousJohn PapastergiouDale GriffithsMarie-Camille ChaumaisKurt E HersbergerReka ViolaEma PaulinoTrudie LobbanLis NeubeckBen FreedmanSotiris AntoniouPublished in: Journal of thrombosis and thrombolysis (2021)
Atrial fibrillation (AF) accounts for up to one third of strokes, one of the lead mortality causes worldwide. The European Society of Cardiology guidelines recommend opportunistic screening as a means to increase the odds of early detection and institution of appropriate treatment according to risk factors identified. However, in most countries there are various barriers to effective uptake of screening, including low awareness. The Atrial Fibrillation Association is a patient association engaged with raising awareness of AF. Establishing a partnership with the International Pharmacists for Anticoagulation Care Taskforce, we set as goals to test a model for raising awareness of AF involving pharmacists globally; and to identify barriers and enablers to its implementation. A cross-sectional study was conducted during the Arrhythmia Alliance World Heart Rhythm Week. Pharmacists from 10 countries invited individuals (≥ 40 years; without anticoagulation therapy of AF) to participate in the awareness campaign. Participants agreeing were engaged in the early detection of AF (EDAF) using pulse palpation. Individuals with rhythm discrepancies were referred and prospectively assessed to have information on the proportion of confirmed diagnosis, leading to estimate the detection rate. Interviews with country coordinators explored barriers and enablers to implementation. The study involved 4193 participants in the awareness campaign and 2762 in the EDAF event (mean age 65.3 ± 13.0), of whom 46.2% individuals were asymptomatic, recruited across 120 sites. Most common CHA2DS2-VASc risk factor was hypertension. Among 161 patients referred to physician, feedback was obtained for 32 cases, of whom 12 new arrhythmia diagnoses were confirmed (5 for AF, 2 for atrial flutter), all among elders (≥ 65 years). Qualitative evaluation suggested a local champion to enable pharmacists' success; technology enhanced engagement amongst patients and increased pharmacists' confidence in referring to physicians; interprofessional relationship was crucial in success. This study suggests pharmacists can contribute to greater outreach of awareness campaigns. Effective communication pathways for inter-professional collaboration were suggested enablers to gain full benefits of EDAF.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- risk factors
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- primary care
- heart failure
- general practice
- healthcare
- blood pressure
- percutaneous coronary intervention
- end stage renal disease
- quality improvement
- type diabetes
- emergency department
- newly diagnosed
- ejection fraction
- chronic kidney disease
- public health
- clinical trial
- stem cells
- case report
- social media
- acute coronary syndrome
- acute kidney injury
- pain management
- peritoneal dialysis
- palliative care